Evidence map›Paper›PMID 28626587›Full record

ArticleJournal of cancer research & therapy2016

Adriana Rico, Lori A Pollack, Trevor D Thompson, Mei-Chin Hsieh, Xiao-Cheng Wu, Jordan J Karlitz, Dee W West, John M Rainey, Vivien W Chen, Enhancement of NPCR for Comparative Effectiveness Research team

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer research & therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Treatment patterns for metastatic colorectal cancer in Spain.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adriana RicoCancer Surveillance Branch, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
Lori A PollackCancer Surveillance Branch, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
Trevor D ThompsonCancer Surveillance Branch, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
Mei-Chin HsiehLouisiana Tumor Registry and Epidemiology Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States.
Xiao-Cheng WuLouisiana Tumor Registry and Epidemiology Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States.
Jordan J KarlitzDivision of Gastroenterology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
Dee W WestCancer Registry of Greater California, Public Health Institute, Sacramento, California, United States.
John M RaineyAcadiana Medical Research Foundation, Lafayette, Louisiana, United States.
Vivien W ChenLouisiana Tumor Registry and Epidemiology Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States.
Enhancement of NPCR for Comparative Effectiveness Research team

Funding

Intramural CDC HHS CC999999NCCDPHP CDC HHS U58 DP000792
6 · The paper itself

Abstract

backgroundIn 2011, the National Comprehensive Cancer Network (NCCN) recommended

methodsTen state population-based registries supported by Centers for Disease Control and Prevention's (CDC) National Program of Cancer Registries (NPCR) collected detailed cancer information on mCRC cases diagnosed in 2011, including

resultsOf the 3,608 mCRC cases, 27% (n = 992) had a documented

conclusionsDespite NCCN guideline recommendations, 73% of mCRC cases diagnosed in 2011 had no documented IMPACT: These findings show the capacity of monitoring

Indexed as

colorectal cancerKRAS testingNPCR registries

Identifiers

PMID28626587
PMCPMC5472357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.